ClinConnect ClinConnect Logo
Search / Trial NCT02708134

Quality of Pediatric Resuscitation in a Multicenter Collaborative

Launched by CHILDREN'S HOSPITAL OF PHILADELPHIA · Mar 9, 2016

Trial Information

Current as of June 27, 2025

Recruiting

Keywords

Chest Compressions Cardiopulmonary Resuscitation

ClinConnect Summary

This clinical trial is studying how well chest compressions are performed during pediatric cardiac arrests and how this affects patient outcomes. Researchers want to understand how factors like the speed and depth of chest compressions, as well as the quality of care after the cardiac event, influence recovery in children. The trial is open to children aged from birth to 17 years who have received at least one minute of chest compressions during a cardiac arrest and have a special device in place to measure the quality of those compressions.

If your child is eligible to participate, they will be part of a study that looks at real-life situations in multiple hospitals. This means they will not receive any new treatments but will be monitored to help gather important information about how to improve care for kids experiencing cardiac arrest. It's important to note that children on a specific type of life support called ECMO at the start of the cardiac arrest won't be included in this study. The findings from this research could help improve emergency care for children in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patient received chest compressions for at least 1 minute
  • Patient between gestational age ≥37 weeks and 17 years of age
  • Patient had a quality of CPR measurements device (eg., Zoll Medical chest compression sensor) in place during chest compressions
  • Exclusion Criteria:
  • Patient on extracorporeal membrane oxygenation (ECMO) therapy at beginning of CPR event

About Children's Hospital Of Philadelphia

The Children's Hospital of Philadelphia (CHOP) is a leading pediatric healthcare institution renowned for its commitment to advancing child health through innovative research and clinical care. As a prominent clinical trial sponsor, CHOP emphasizes a multidisciplinary approach to pediatric research, fostering collaborations across various specialties to develop and evaluate groundbreaking therapies and interventions. With a focus on improving patient outcomes and enhancing the quality of life for children, CHOP is dedicated to conducting rigorous clinical trials that adhere to the highest ethical standards and scientific integrity, ultimately contributing to the global knowledge base in pediatric medicine.

Locations

Charleston, South Carolina, United States

Baltimore, Maryland, United States

Boston, Massachusetts, United States

Lebanon, New Hampshire, United States

Milwaukee, Wisconsin, United States

Philadelphia, Pennsylvania, United States

Los Angeles, California, United States

Saint Louis, Missouri, United States

Saint Petersburg, Florida, United States

Philadelphia, Pennsylvania, United States

Cincinnati, Ohio, United States

Palo Alto, California, United States

Albany, New York, United States

Columbus, Ohio, United States

Seattle, Washington, United States

Indianapolis, Indiana, United States

Westmead, New South Wales, Australia

Singapore, , Singapore

Los Angeles, California, United States

Chapel Hill, North Carolina, United States

Albany, New York, United States

Dallas, Texas, United States

Taipei, , Taiwan

Dallas, Texas, United States

Cincinnati, Ohio, United States

Los Angeles, California, United States

San Diego, California, United States

Chicago, Illinois, United States

Omaha, Nebraska, United States

Edmonton, Alberta, Canada

Columbus, Ohio, United States

London, , United Kingdom

Iowa City, Iowa, United States

New York, New York, United States

Austin, Texas, United States

Dallas, Texas, United States

Chicago, Illinois, United States

Bogotá, , Colombia

New York, New York, United States

Queens, New York, United States

Saint Petersburg, Florida, United States

Austin, Texas, United States

Singapore, , Singapore

Tokyo, , Japan

Boston, Massachusetts, United States

Richmond, Virginia, United States

Atlanta, Georgia, United States

Lexington, Kentucky, United States

Atlanta, Georgia, United States

Akron, Ohio, United States

Richmond, Virginia, United States

Syracuse, New York, United States

Orange, California, United States

Aurora, Colorado, United States

Akron, Ohio, United States

Vancouver, British Columbia, Canada

Calgary, , Canada

Wilmington, Delaware, United States

Patients applied

0 patients applied

Trial Officials

Vinay Nadkarni, MD, MS

Principal Investigator

Children's Hospital of Philadelphia

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials